, Guideline contributors Austria 1

, Belgium, vol.1, issue.21

. Brunei,

. Cyprus,

. Denmark,

, French Guiana, vol.1

, Greece ?, vol.41, issue.2

, Guatemala, vol.1, issue.1

. Israel,

. Ireland,

, Lebanon, issue.11

. Qatar,

. Taiwan,

, United Arab Emirates, vol.1

D. Denning, I. Page, and J. Chakaya, Case definition of chronic pulmonary aspergillosis in resource-constrained settings):e171312. https, Emerg Infect Dis, vol.24, issue.8, 2018.

J. Jarvis, N. Govender, and T. Chiller, Cryptococcal Antigen Screening and Preemptive Therapy in Patients Initiating Antiretroviral Therapy in Resource-Limited Settings, Journal of the International Association of Physicians in AIDS Care, vol.53, issue.4, pp.374-379, 2012.
DOI : 10.1093/cid/cir379

A. Ullmann, J. Aguado, and S. Arikan-akdagli, Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline, Clinical Microbiology and Infection, vol.24, issue.1, pp.1-38, 2018.
DOI : 10.1016/j.cmi.2018.01.002

URL : https://hal.archives-ouvertes.fr/hal-01953645

S. Heldt, J. Prattes, and S. Eigl, Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples, Journal of Infection, vol.77, issue.3, 2018.
DOI : 10.1016/j.jinf.2018.05.001

I. Martin-loeches, M. Schultz, and J. Vincent, Increased incidence of co-infection in critically ill patients with influenza, Intensive Care Medicine, vol.3, issue.Suppl 2, pp.48-58, 2017.
DOI : 10.1016/S2213-2600(15)00278-7

J. Prattes, H. Flick, and F. Pruller, Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases, American Journal of Respiratory and Critical Care Medicine, vol.189, issue.8
DOI : 10.1097/QCO.0000000000000005

, Am J Respir Crit Care Med, vol.190, issue.8, pp.922-929, 2014.

S. Vallabhaneni and T. Chiller, Fungal Infections and New Biologic Therapies, Current Rheumatology Reports, vol.64, issue.12, p.29, 2016.
DOI : 10.1002/acr.21784

S. Eigl, M. Hoenigl, and B. Spiess, Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis, Med Mycol, vol.55, issue.5, pp.528-534, 2017.

G. Chamilos, M. Lionakis, and D. Kontoyiannis, Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways, Clinical Infectious Diseases, vol.10, issue.1, pp.140-148, 2018.
DOI : 10.1371/journal.pone.0137641

D. Perlin, R. Rautemaa-richardson, and A. Alastruey-izquierdo, The global problem of antifungal resistance: prevalence, mechanisms, and management, The Lancet Infectious Diseases, vol.17, issue.12, pp.383-392, 2017.
DOI : 10.1016/S1473-3099(17)30316-X

K. Saris, J. Meis, A. Voss, and . Candida-auris, Curr Opin Infect Dis, vol.31, issue.4, pp.334-340, 2018.

M. Mccarthy and T. Walsh, Expert Review of Anti-infective Therapy, vol.53, issue.6, pp.1095-1099, 2017.
DOI : 10.1128/AAC.01056-17

A. Chowdhary, C. Sharma, and J. Meis, Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally, PLOS Pathogens, vol.389, issue.5, p.1006290, 2017.
DOI : 10.1371/journal.ppat.1006290.t001

I. Schwartz, C. Kenyon, and R. Lehloenya, AIDS-Related Endemic Mycoses in Western Cape, South Africa, and Clinical Mimics: A Cross-Sectional Study of Adults With Advanced HIV and Recent-Onset, Widespread Skin Lesions, Open Forum Infectious Diseases, vol.50, issue.4, p.186, 2017.
DOI : 10.3109/13693786.2011.596288

I. Schwartz, S. Sanche, N. Wiederhold, T. Patterson, and L. Sigler, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America, Emerging Infectious Diseases, vol.24, issue.4, pp.758-761, 2018.
DOI : 10.3201/eid2404.171765

C. Kenyon, K. Bonorchis, and C. Corcoran, A Dimorphic Fungus Causing Disseminated Infection in South Africa, New England Journal of Medicine, vol.369, issue.15, pp.1416-1424, 2013.
DOI : 10.1056/NEJMoa1215460

K. Dukik, J. Munoz, and Y. Jiang, Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales)

, Mycoses, vol.60, issue.5, pp.296-309, 2017.

J. Jenks, S. Reed, and D. Seidel, Rare Mold Infections Caused by Mucorales, Lomentospora Prolificans and Fusarium , San Diego: The Role of Antifungal Combination Therapy, International Journal of Antimicrobial Agents, 2018.
DOI : 10.1016/j.ijantimicag.2018.08.005

J. Jenks, H. Salzer, J. Prattes, R. Krause, D. Buchheidt et al., Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy, Drug Design, Development and Therapy, vol.12, pp.1033-1044, 2018.
DOI : 10.2147/DDDT.S145545

M. Hoenigl, J. Prattes, P. Neumeister, A. Wolfler, and R. Krause, Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study, Mycoses, vol.26, issue.3, pp.201-205, 2018.
DOI : 10.1592/phco.26.12.1730

M. Mccarthy, D. Kontoyiannis, O. Cornely, J. Perfect, and T. Walsh, Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi, The Journal of Infectious Diseases, vol.13, issue.22, pp.474-483, 2017.
DOI : 10.1016/S1473-3099(12)70293-1

M. Mccarthy, R. Petraitiene, and T. Walsh, Nucleic acid amplification methodologies for the detection of pulmonary mold infections, Expert Review of Molecular Diagnostics, vol.4, issue.3, pp.271-279, 2017.
DOI : 10.1126/scitranslmed.3005377

S. Heldt, S. Eigl, and J. Prattes, Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis, Mycoses, vol.54, issue.Suppl 1, pp.818-825, 2017.
DOI : 10.3414/ME14-01-0113

W. Florio, A. Tavanti, S. Barnini, E. Ghelardi, and A. Lupetti, Recent Advances and Ongoing Challenges in the Diagnosis of Microbial Infections by MALDI-TOF Mass Spectrometry, Frontiers in Microbiology, vol.8, p.1097, 2018.
DOI : 10.1371/journal.pone.0056139

M. Hoenigl, S. Eigl, S. Heldt, W. Duettmann, C. Thornton et al., Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis, Mycoses, vol.70, issue.1, pp.40-43, 2018.
DOI : 10.1016/j.jinf.2014.11.005

O. Cornely, C. Lass-florl, K. Lagrou, V. Arsic-arsenijevic, and M. Hoenigl, Improving outcome of fungal diseases - Guiding experts and patients towards excellence, Mycoses, vol.47, issue.Suppl 3, pp.420-425, 2017.
DOI : 10.1183/13993003.00583-2015

D. Seidel, D. Graeff, L. Vehreschild, and M. , -Global Emerging Fungal Infection Registry, Mycoses, vol.60, issue.Suppl 3, pp.508-516, 2017.
DOI : 10.1111/myc.12595

D. Graeff, L. Seidel, D. Vehreschild, and M. , species: Report of 23 cases from the FungiScope Registry, Mycoses, vol.16, issue.Suppl 7, pp.273-279, 2017.
DOI : 10.1016/S1473-3099(16)00071-2

F. Marty, L. Ostrosky-zeichner, and O. Cornely, Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis, The Lancet Infectious Diseases, vol.16, issue.7, pp.828-837, 2016.
DOI : 10.1016/S1473-3099(16)00071-2

S. Deng, W. Lei, and G. De-hoog, ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.5, issue.6, 2018.
DOI : 10.1517/14656566.5.2.247

S. Schelenz, R. Barnes, and R. Barton, British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases, The Lancet Infectious Diseases, vol.15, issue.4, pp.461-474, 2015.
DOI : 10.1016/S1473-3099(15)70006-X

B. Kavanagh, The GRADE System for Rating Clinical Guidelines, PLoS Medicine, vol.299, issue.9, p.1000094, 2009.
DOI : 10.1001/jama.299.6.646

M. Brouwers, K. Kerkvliet, and K. Spithoff, AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines, BMJ, vol.352, p.1152, 2016.

M. Brouwers, M. Kho, and G. Browman, AGREE II: advancing guideline development, reporting and evaluation in health care, Canadian Medical Association Journal, vol.182, issue.18, pp.839-842, 2010.
DOI : 10.1503/cmaj.090449

M. Brouwers, M. Kho, and G. Browman, Development of the AGREE II, part 1: performance, usefulness and areas for improvement, Canadian Medical Association Journal, vol.182, issue.10, pp.1045-1052, 2010.
DOI : 10.1503/cmaj.091714

M. Hoenigl, J. Gangneux, and E. Segal, Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together, Mycoses, vol.182, issue.10, pp.1-10, 2018.
DOI : 10.1503/cmaj.091714

URL : https://hal.archives-ouvertes.fr/hal-01863269